Cui Ma
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Pulmonary Hypertension Research and Treatments
Papers in
-
- MicroRNA in disease regulation 10
- Cancer-related molecular mechanisms research 9
-
- Pulmonary Hypertension Research and Treatments 23
- Co-authors
- Daling Zhu (37 shared papers)Lixin Zhang (27 shared papers)Yong‐Ning Zhou (16 shared papers)Xiaodong Zheng (17 shared papers)Siyu He (13 shared papers)Xijuan Zhao (15 shared papers)Xin Wei (11 shared papers)Jian Chun Bao (12 shared papers)
- Journals
- European Journal of Pharmacology (5 papers)Chemical Engineering Journal (4 papers)American Journal of Physiology-Lung Cellular and Molecular Physiology (3 papers)Hypertension (3 papers)Arteriosclerosis Thrombosis and Vascular Biology (3 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Cui Ma
132 papers receiving 3.0k citations
Peers
Comparison fields: 5 of 146
- Cancer Research 492
- Pulmonary and Respiratory Medicine 645
- Biochemistry 132
- Molecular Biology 1.1k
- Biological Psychiatry 28
Countries citing papers authored by Cui Ma
This map shows the geographic impact of Cui Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cui Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cui Ma more than expected).
Fields of papers citing papers by Cui Ma
This network shows the impact of papers produced by Cui Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cui Ma. The network helps show where Cui Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Cui Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 137 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 119 | |
| 2 | 2010 | 109 | |
| 3 | 2011 | 93 | |
| 4 | 2021 | 77 | |
| 5 | 2020 | 75 | |
| 6 | 2012 | 72 | |
| 7 | 2019 | 70 | |
| 8 | 2018 | 65 | |
| 9 | 2022 | 63 | |
| 10 | 2022 | 62 | |
| 11 | 2018 | 61 | |
| 12 | 2021 | 61 | |
| 13 | 2021 | 61 | |
| 14 | 2020 | 60 | |
| 15 | 2021 | 57 | |
| 16 | 2018 | 56 | |
| 17 | 2018 | 55 | |
| 18 | 2019 | 55 | |
| 19 | 2016 | 55 | |
| 20 | 2020 | 50 |
About Cui Ma
Cui Ma is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Molecular Biology, Biochemistry and Automotive Engineering, having authored 137 papers that have together received 3.0k indexed citations. Recurring topics across this work include Pulmonary Hypertension Research and Treatments (23 papers), Advancements in Battery Materials (18 papers), Advanced Battery Materials and Technologies (14 papers), RNA modifications and cancer (13 papers), MicroRNA in disease regulation (10 papers), Eicosanoids and Hypertension Pharmacology (10 papers), Cancer-related molecular mechanisms research (9 papers) and Circular RNAs in diseases (9 papers). The work is most often cited by research in Cancer Research (492 citations), Pulmonary and Respiratory Medicine (645 citations), Biochemistry (132 citations), Molecular Biology (1.1k citations) and Biological Psychiatry (28 citations). Cui Ma has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Daling Zhu, Lixin Zhang, Yong‐Ning Zhou, Xiaodong Zheng, Siyu He, Xijuan Zhao, Xin Wei, Jian Chun Bao, Jun Ma and Xun‐Lu Li. Their work appears in journals such as European Journal of Pharmacology, Chemical Engineering Journal, American Journal of Physiology-Lung Cellular and Molecular Physiology, Hypertension and Arteriosclerosis Thrombosis and Vascular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.